Roivant Sciences Ltd.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ROIV

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

2,084,609

Value ($000)

45,236

Weight

0.0%

2022 Q2 - 2025 Q4 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	45,236	0.0%	2,084,609	12/31/2025
2025 Q3	11/14/2025	32,130	0.0%	2,123,617	9/30/2025
2025 Q2	8/14/2025	31,278	0.0%	2,775,349	6/30/2025
2025 Q1	5/19/2025	24,678	0.0%	2,445,807	3/31/2025
2024 Q4	2/14/2025	28,528	0.0%	2,411,466	12/31/2024
2024 Q3	11/14/2024	26,625	0.0%	2,307,178	9/30/2024
2024 Q2	8/14/2024	16,322	0.0%	1,544,225	6/30/2024
2024 Q1	5/15/2024	12,062	0.0%	1,144,428	3/31/2024
2023 Q4	2/14/2024	12,877	0.0%	1,146,632	12/31/2023
2023 Q3	11/13/2023	12,255	0.0%	1,049,200	9/30/2023
2023 Q2	8/11/2023	2,214	0.0%	300,009	6/30/2023
2023 Q1	5/15/2023	2,214	0.0%	300,009	3/31/2023
2022 Q4	2/14/2023	2,605	0.0%	326,042	12/31/2022
2022 Q3	11/14/2022	878	0.0%	272,549	9/30/2022
2022 Q2	8/12/2022	964	0.0%	236,766	6/30/2022